REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Girispharma S.A. (Ecuador)

Main Activities: Pharmaceutical and Medicine Manufacturing
Secondary Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Girispharma S.A. Profile Updated: May 14, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Girispharma S.A. is a company based in Ecuador, with its head office in Quito. The company operates in the Pharmaceutical and Medicine Manufacturing sector. The company was established on May 29, 2019. The total number of employees is currently 4 (2022). There was a net sales revenue drop of 83.34% reported in Girispharma S.A.’s latest financial highlights for 2023. Over the same period, its total assets grew by 98.72%.

Headquarters
Manosca N 36 10
Quito; Pichincha;

Contact Details: Purchase the Girispharma S.A. report to view the information.

Basic Information
Total Employees:
Purchase the Girispharma S.A. report to view the information.
Outstanding Shares:
Purchase the Girispharma S.A. report to view the information.
Registered Capital:
Purchase the Girispharma S.A. report to view the information.
Incorporation Date:
May 29, 2019
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
93.87%
Purchase this report to view the information.
5%
Purchase this report to view the information.
1%
Purchase this report to view the information.
0.03%
Purchase this report to view the information.
0.03%
Company Performance
Financial values in the chart are available after Girispharma S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
-83.34%▼
Total operating revenue
-83.34%▼
Operating profit (EBIT)
99.99%▲
Net Profit (Loss) for the Period
N/A
Total assets
98.72%▲
Total equity
-1.58%▼
Operating Profit Margin (ROS)
99.82%▲
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Quick Ratio
-42.2%▼
Cash Ratio
-42.22%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo